article thumbnail

Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study

Drug Topics

Recent Videos Related Content FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1 Killian Meara July 10th 2025 Article The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.

article thumbnail

Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShare

Drug Topics

The community pharmacy sector is facing unprecedented challenges, with shrinking margins and evolving health care dynamics putting increasing pressure on independent pharmacies. There's going to be reimbursement pressures that pharmacies are faced with when it comes to script revenue," Flaugher said.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Drug Topics

Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? 2026 Edition. Sign up today for our free Drug Topics newsletter. REFERENCES 1. Yellow Book. Updated April 23, 2025. Accessed May 16, 2025. The Immunization Action Coalition. Travel Vaccines. Updated October 11, 2024.

Vaccines 345
article thumbnail

Five for Friday July 18: Celebrating Success in Advancing Medication Use Quality

PQA

PQA is developing its next strategic plan, Blueprint PQA 2030, which will guide the organization’s work from 2026 through 2030. Innovating to Advance Pharmacy Services PQA Board member Amina Abubakar, who represents CPESN USA, discusses the innovative approaches she's taken to build successful independent pharmacies.

article thumbnail

Turning Reconciliation into a Revenue Growth Engine

Drug Topics

These initiatives will dramatically impact pharmacy reimbursements, potentially reducing payments for high-cost medications and introducing new administrative complexities. RCM emerges as a crucial solution for pharmacies to streamline billing processes, identify and recover missing revenue, and maintain operational efficiency.

article thumbnail

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

Merck said in the release that it anticipates ordering of clesrovimab-cfor to begin in July, with shipments being delivered before the start of the 2025-2026 RSV season. The therapy should not be given to infants with a history of serious hypersensitivity reactions to any of its ingredients.

FDA 432
article thumbnail

Locked in a federal stalemate, states take PBM reform into their own hands

PharmaVoice

The nation’s three largest PBMs — CVS Caremark, OptumRx and Cigna’s Express Scripts — control roughly 80% of the market and operate their own pharmacies. 1, 2026, The healthcare giant also said the law would result in Arkansas paying more for prescription drugs. But even without CVS, other pharmacies could amass more market share.